Bevacizumab for the treatment of rubeotic/neovascular glaucoma and uncontrolled Proliferative Diabetic Retinopathy prior to laser or vitrectomy (adults)

  • by
Download
  • Version
  • Download 1101
  • File Size 64.08 KB
  • File Count 1
  • Create Date May 7, 2020
  • Last Updated September 7, 2020

Bevacizumab for the treatment of rubeotic/neovascular glaucoma and uncontrolled Proliferative Diabetic Retinopathy prior to laser or vitrectomy (adults)

Rubeotic glaucoma

neovascular glaucoma

Proliferative Diabetic Retinopathy

bevacizumab

Attached Files

FileAction
Bevacizumab-Policy-rubeotic-glaucome-and-PDR-prior-to-laser-or-vitrectomy-May-19-update.pdfDownload